A

Arrowhead Pharmaceuticals
D

ARWR

15.750
USD
-0.48
(-2.96%)
مغلق
حجم التداول
48,438
الربح لكل سهم
-3
العائد الربحي
-
P/E
-13
حجم السوق
2,175,081,851
أصول ذات صلة
ALNY
ALNY
3.30
(1.08%)
308.00 USD
C
CRSP
0.050
(0.12%)
41.360 USD
E
EDIT
-0.20500
(-9.45%)
1.96500 USD
I
IONS
-0.020
(-0.06%)
35.570 USD
MRNA
MRNA
-0.670
(-2.45%)
26.680 USD
N
NTLA
-0.04000
(-0.48%)
8.31000 USD
REGN
REGN
7.50
(1.44%)
529.39 USD
S
SGMO
-0.02290
(-4.55%)
0.48010 USD
S
SRPT
-1.080
(-2.90%)
36.170 USD
VRTX
VRTX
-4.36
(-0.95%)
455.70 USD
المزيد
الأخبار المقالات

العنوان: Arrowhead Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.